NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 65 filers reported holding NEOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $66,000 | – | 39,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,858,889 | $7,337,000 | 5.11% |
| Proxima Capital Management, LLC | 170,294 | $257,000 | 0.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,530,731 | $5,331,000 | 0.44% |
| Nantahala Capital Management | 4,610,000 | $6,961,000 | 0.21% |
| Wealthstar Advisors, LLC | 73,295 | $111,000 | 0.07% |
| Alambic Investment Management, L.P. | 51,733 | $78,000 | 0.06% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $151,000 | 0.05% |
| BCS Wealth Management | 29,520 | $45,000 | 0.03% |
| Allred Capital Management, LLC | 24,995 | $37,742,000 | 0.02% |
| ALGERT GLOBAL LLC | 34,254 | $52,000 | 0.02% |